The 10th Complement-based Drug Development Summit addresses innovations, clinical progress, and emerging applications in complement-targeted therapeutics across multiple disease areas.
Key Topics
Expansion of complement therapeutics into autoimmunity, oncology, and non-rare diseases
Advancement of preclinical research and new technologies in the complement field
Novel modalities for improved precision, comfort, and treatment adherence
Complement biomarkers for diagnosis and efficacy monitoring
Progress in safety and efficacy studies with regulatory and vaccination considerations
Clinical learnings from nephrology, ophthalmology, and hematology
